| APL-501 or Nivolumab in Combination With APL-101 in Locally Advanced or Metastatic HCC and RCC (NCT03655613) | Apollomics (Australia) Pty. Ltd. | 2018-09-05 |
| Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation (NCT03839706) | University Health Network, Toronto | 2018-08-22 |
| ThinkRadial: A Prospective Study of Transradial deTACE in HCC Patients (NCT07160374) | Asan Medical Center | 2018-08-21 |
| HCC Screening Using DNA Methylation Changes in ctDNA (NCT03483922) | HKGepitherapeutics | 2018-08-20 |
| Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System (NCT03889093) | University of Minnesota | 2018-08-09 |
| Trial Comparing PLA to HIGRT (PROVE-HCC) (NCT03402607) | Duke University | 2018-08-08 |
| Randomized Study of Adjuvant Radiotherapy After Curative Resection of HCC With Narrow Margin (RAISE) (NCT03732105) | Sun Yat-sen University | 2018-08-08 |
| Dual TORC1/TORC2 Inhibitor ATG-008 (CC-223) in HBV Positive Advanced Hepatocellular Carcinoma (HCC) Subjects (NCT03591965) | Antengene Therapeutics Limited | 2018-08-07 |
| Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC (NCT03812770) | Sun Yat-sen University | 2018-08-04 |
| Effects of Anesthetic Methods on Hepatic Cancer Cell Malignancy (NCT03594188) | RenJi Hospital | 2018-07-23 |
| Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS) (NCT03739164) | Florida Hospital Tampa Bay Division | 2018-07-18 |
| CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma (NCT03582618) | TaiRx, Inc. | 2018-07-12 |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors (NCT03517488) | Xencor, Inc. | 2018-07-10 |
| Mild Hypothermia and Acute Kidney Injury in Liver Transplantation (NCT03534141) | University of California, San Francisco | 2018-07-07 |
| TACE-HAIC vs. HAIC for Potentially Resectable HCC (NCT03591705) | Sun Yat-sen University | 2018-07-06 |
| TACE Combined With Iodine-125 Seeds Implantation for HCC (NCT03322280) | Second Affiliated Hospital of Guangzhou Medical University | 2018-07-01 |
| The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent Hepatectomy (NCT03851913) | Sun Yat-sen University | 2018-07-01 |
| A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors (NCT03695952) | Asan Medical Center | 2018-07-01 |
| Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular Carcinoma (NCT03609151) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-06-30 |
| Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma (NCT03285867) | Nanfang Hospital, Southern Medical University | 2018-06-25 |
| A Study of PTS100 in Primary HCC Patients (NCT03447951) | Gongwin Biopharm Co., Ltd. | 2018-06-19 |
| Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment (NCT03686709) | University of Tennessee | 2018-06-19 |
| A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies (NCT03538028) | Incyte Biosciences International Sàrl | 2018-06-18 |
| Chemoembolization Using LifePearl Polyethylene Glycol Drug Eluting Microspheres With Doxorubicin in HCC (NCT03734068) | International Group of Endovascular Oncology | 2018-06-13 |
| Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy (NCT03755791) | Exelixis | 2018-06-10 |
| Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE (NCT03722498) | Sun Yat-sen University | 2018-06-01 |
| A Study of TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation (NCT02686372) | Lion TCR Pte. Ltd. | 2018-05-16 |
| Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer (NCT03482102) | Massachusetts General Hospital | 2018-05-14 |
| A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (NCT03475953) | Institut Bergonié | 2018-05-04 |
| The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients (NCT03511703) | Guangxi Medical University | 2018-05-01 |
| The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus (NCT03520257) | Guangxi Medical University | 2018-05-01 |
| Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma (NCT03515369) | Eastern Hepatobiliary Surgery Hospital | 2018-05-01 |
| Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma (NCT03245190) | Chipscreen Biosciences, Ltd. | 2018-04-28 |
| A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma (NCT03519997) | David Hsieh | 2018-04-26 |
| Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study (NCT03405909) | University Hospital Erlangen | 2018-04-21 |
| A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation (NCT03383458) | Bristol-Myers Squibb | 2018-04-18 |
| SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization Therapy (NCT04015245) | Chimei Medical Center | 2018-04-12 |
| Nivolumab and Bevacizumab in Patients With Advanced and or Metastatic Hepatocellular Carcinoma (NCT03382886) | University of Utah | 2018-04-11 |
| Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma (NCT03628651) | Exact Sciences Corporation | 2018-04-02 |
| HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC (NCT03468231) | Sun Yat-sen University | 2018-03-09 |
| Direct Acting Antiviral-Post Authorization Safety Study (NCT03707080) | Target PharmaSolutions, Inc. | 2018-03-09 |
| Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria (NCT03469479) | Sun Yat-sen University | 2018-03-02 |
| Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test (NCT03493763) | Shanghai Zhongshan Hospital | 2018-03-01 |
| Study of Adoptive Transfer of iNKT Cells Combined With TAE/TACE to Treat Unresectable HCC (NCT04011033) | Beijing YouAn Hospital | 2018-03-01 |
| Determination of Autonomic Responses to the Exposure of Low Energy Electromagnetic Fields With Frequency Modulation in Patients With Advanced Hepatocellular Carcinoma and Healthy Individuals. (NCT03448757) | Hospital Sirio-Libanes | 2018-02-15 |
| Study of Pembrolizumab and Radiotherapy in Liver Cancer (NCT03316872) | University Health Network, Toronto | 2018-02-15 |
| Characterization of Methylation Patterns in Hepatocellular Carcinoma (NCT04264754) | Nucleix Ltd. | 2018-02-13 |
| Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis (NCT03311152) | Central Hospital, Nancy, France | 2018-02-12 |
| A Study of Individualized Radiotherapy Based on a Prediction Model of Lymph Node Metastasis in Hepatocellular Carcinoma (NCT03416803) | Shanghai Zhongshan Hospital | 2018-02-01 |
| The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. (NCT04053972) | Sun Yat-sen University | 2018-01-31 |
| FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors (NCT03319459) | Fate Therapeutics | 2018-01-18 |
| Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma (NCT02799212) | Hospices Civils de Lyon | 2018-01-10 |
| Role of LDH as a Predictor of Treatment Outcomes in Hepatocellular Carcinoma (NCT03338166) | Assiut University | 2018-01-02 |
| Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin (NCT03259581) | University of Minnesota | 2018-01-02 |
| Diagnostic Value of AFP-L3 and PIVKA-II in HCC (NCT03460080) | Hanoi Medical University | 2018-01-01 |
| Vienna Hypothermic Oxygenated Machine Perfusion Study (NCT06418165) | Medical University of Vienna | 2018-01-01 |
| The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC) (NCT04053985) | Sun Yat-sen University | 2018-01-01 |
| Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma (NCT04627012) | Sun Yat-sen University | 2018-01-01 |
| Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors (NCT03302403) | Kang YU | 2017-12-29 |
| Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib (NCT03163992) | Samsung Medical Center | 2017-12-26 |
| Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea (NCT03586050) | Ethicon, Inc. | 2017-12-11 |
| ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma (NCT03888859) | First Affiliated Hospital Xi'an Jiaotong University | 2017-12-06 |
| Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies (NCT03422679) | Cellestia Biotech AG | 2017-12-05 |
| A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s) (NCT03232593) | Hoffmann-La Roche | 2017-11-29 |
| Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation (NCT03490461) | Yonsei University | 2017-11-22 |
| Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique (NCT03375281) | Seoul National University Hospital | 2017-11-20 |
| Study of Apatinib Combined With TACE in Advance Hepatocellular Carcinoma (NCT03398122) | Tianjin Medical University Cancer Institute and Hospital | 2017-11-14 |
| Pembrolizumab as Neoadjuvant Treatment in HCC (NCT03337841) | Kindai University | 2017-11-10 |
| Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization (NCT03300401) | University of Southern California | 2017-11-07 |
| Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant Eligibility (NCT03342677) | University Health Network, Toronto | 2017-11-07 |
| Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation (NCT02580253) | Zhejiang University | 2017-11-01 |
| A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA (NCT03124498) | Chuan An Biotechnology Co., Ltd. | 2017-11-01 |
| MicroRNAs as Diagnostic Biomarkers in Hepatocellular Carcinoma Among Somali Patients (NCT03227510) | People's Friendship University of Russia | 2017-11-01 |
| Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion (NCT02678806) | Guangxi Medical University | 2017-11-01 |
| Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging (NCT03303469) | University of Alabama at Birmingham | 2017-10-30 |
| SBRT or TACE for Advanced HCC (NCT03338647) | University of Aarhus | 2017-10-26 |
| Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation (NCT02935478) | St. Louis University | 2017-10-18 |
| Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma (NCT03298451) | AstraZeneca | 2017-10-11 |
| Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma (NCT03349255) | Aeon Therapeutics (Shanghai) Co., Ltd. | 2017-10-06 |
| Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial (NCT03551444) | Ain Shams University | 2017-10-01 |
| Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC (NCT04221347) | Military University Hospital, Prague | 2017-10-01 |
| Cytidine-phosphate-guanosine (CpG) DNA in Hepatocellular Carcinoma Combination Therapy (NCT03235167) | Dalian University | 2017-10-01 |
| Nivolumab With or Without Ipilimumab in Treating Patients With Resectable Liver Cancer (NCT03222076) | M.D. Anderson Cancer Center | 2017-09-28 |
| IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients (NCT03203005) | National Cancer Institute, Naples | 2017-09-18 |
| A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC (NCT03380130) | Clinica Universidad de Navarra, Universidad de Navarra | 2017-09-11 |
| Enhanced Radiofrequency Ablation for Recurrent HCC Post-TACE Using Twin Internally Cooled-Perfusion Electrodes (NCT07192172) | Seoul National University Hospital | 2017-09-01 |
| Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers (NCT03190174) | Sarcoma Oncology Research Center, LLC | 2017-08-24 |
| HEPAR Primary: Holmium-166-radioembolization in Hepatocellular Carcinoma Patients (NCT03379844) | UMC Utrecht | 2017-08-21 |
| Targeted and Staged Cyber Knife Combined With Interventional Therapy in the Treatment of MHCC (NCT03243916) | Chinese PLA General Hospital | 2017-08-15 |
| A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism (NCT03139487) | Asan Medical Center | 2017-08-07 |
| Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular Carcinoma (NCT03109886) | Tiziana Life Sciences LTD | 2017-07-12 |
| Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere® (NCT03203837) | Northwestern University | 2017-07-05 |
| GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression (NCT03198546) | Second Affiliated Hospital of Guangzhou Medical University | 2017-07-01 |
| Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE) (NCT02997956) | University of Michigan Rogel Cancer Center | 2017-07-01 |
| Combination of TATE and PD-1 Inhibitor in Liver Cancer (NCT03259867) | Teclison Ltd. | 2017-07-01 |
| The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. (NCT03192644) | Sun Yat-sen University | 2017-07-01 |
| Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer (NCT03199274) | Thomas Jefferson University | 2017-07-01 |
| The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. (NCT03192618) | Sun Yat-sen University | 2017-07-01 |
| Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma (NCT03198975) | Ming Kuang | 2017-06-23 |
| Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors (NCT03507998) | Curegenix Inc. | 2017-06-17 |